Pulmatrix, Inc. (PULM)
1.55
+0.16
(+11.11%)
USD |
NASDAQ |
Sep 09, 13:58
Pulmatrix Shareholders Equity (Quarterly) : 2.557M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.557M |
| March 31, 2026 | 3.591M |
| December 31, 2025 | 3.81M |
| September 30, 2025 | 4.733M |
| June 30, 2025 | 5.604M |
| March 31, 2025 | 7.147M |
| December 31, 2024 | 8.947M |
| September 30, 2024 | 10.92M |
| June 30, 2024 | 13.31M |
| March 31, 2024 | 19.02M |
| December 31, 2023 | 18.00M |
| September 30, 2023 | 19.88M |
| June 30, 2023 | 23.45M |
| March 31, 2023 | 27.01M |
| December 31, 2022 | 31.11M |
| September 30, 2022 | 35.05M |
| June 30, 2022 | 38.44M |
| March 31, 2022 | 42.76M |
| December 31, 2021 | 47.45M |
| September 30, 2021 | 45.19M |
| June 30, 2021 | 53.09M |
| March 31, 2021 | 56.65M |
| December 31, 2020 | 23.14M |
| September 30, 2020 | 23.50M |
| June 30, 2020 | 13.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.936M |
| December 31, 2019 | 11.02M |
| September 30, 2019 | 14.73M |
| June 30, 2019 | 18.09M |
| March 31, 2019 | 10.20M |
| December 31, 2018 | 11.84M |
| September 30, 2018 | 12.63M |
| June 30, 2018 | 16.80M |
| March 31, 2018 | 7.528M |
| December 31, 2017 | 10.14M |
| September 30, 2017 | 12.78M |
| June 30, 2017 | 15.79M |
| March 31, 2017 | 15.90M |
| December 31, 2016 | 8.761M |
| September 30, 2016 | 17.47M |
| June 30, 2016 | 20.15M |
| March 31, 2016 | 28.17M |
| December 31, 2015 | 32.61M |
| September 30, 2015 | 35.91M |
| June 30, 2015 | 39.31M |
| March 31, 2015 | -44.99M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 14.63M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.246M |
| Total Liabilities (Quarterly) | 0.689M |
| Current Ratio | 4.701 |